Investor Presentaiton

16 Global Clinical Trial Progress Rapidly R 启明医疗 VENUSMEDTECH TR TRICUSPID valve MITRAL valve MR ➤ Completed successfully implantation in 13 patients (compassionate route in Canada, Italy and Germany) EFS in Europe ongoing EFS in US in preparation, approved as a breakthrough designated therapy ➤ Completed successfully a clinical study in 11 patients, the longest follow-up, of the first patient, is approaching 4 years ➤ AHEAD EU study commenced in 5 European Countries ➤ AHEAD US EFS study in preparation

View entire presentation